Pfizer

The drug's efficacy as a treatment for ulcerative colitis is currently being assessed in a mid-stage study

Glenmark Pharma earlier had also received tentative approval by the US Food and Drug Administration (FDA) for their generic…

The Duke Clinical Research Institute is supervising the study, which is scheduled to start on 1st January

The drugmaker, which developed and sells the vaccine with Germany's BioNTech said last week that it is targetting a range of $110…

The agency also authorised Pfizer-BioNTech's and Moderna's vaccines for children as young six months

The US has given the go-ahead for booster vaccines that target the currently circulating BA.4 and BA.5 subvariants of Omicron

Japan in January expanded use of the vaccine to those as young as five years old

The company intends to file for regulatory approval in the EU in the next few months

Zantac, originally marketed by a forerunner of GSK, has been sold by several companies at different times, including Pfizer,…

Phase-III trial demonstrates that the investigational pentavalent meningococcal vaccine (MenABCWY) was well-tolerated with an…